As we have been discussing here, the FDA should be sending RVX a letter in mid December (30 days after their Nov 13 meeting).
My question is whether RVX has to release contents of the letter (or some summary) to the markets. This is a material development, so my bias is that it should be released...but more experienced investors than me are better placed to answer my query.
Thanks
Iconoclast